Integrated Diagnostics begins operations with $30mm Series A
Integrated Diagnostics (blood tests using a systems biology approach) has officially started operations and concurrently raised $30mm in its Series A financing from lead investor InterWest Partners, which was joined by the Wellcome Trust and dievini Hopp Biotech. The financing will occur in three tranches, the first of which, totalling $10mm, has been received.
- In Vitro Diagnostics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com